Teleflex Inc (TFX)
211.11
+3.84
(+1.85%)
USD |
NYSE |
Apr 23, 16:00
211.24
+0.13
(+0.06%)
After-Hours: 20:00
Teleflex Enterprise Value: 11.53B for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 23, 2024 | 11.53B |
April 22, 2024 | 11.35B |
April 19, 2024 | 11.31B |
April 18, 2024 | 11.35B |
April 17, 2024 | 11.39B |
April 16, 2024 | 11.48B |
April 15, 2024 | 11.51B |
April 12, 2024 | 11.68B |
April 11, 2024 | 11.82B |
April 10, 2024 | 11.86B |
April 09, 2024 | 12.12B |
April 08, 2024 | 11.80B |
April 05, 2024 | 11.79B |
April 04, 2024 | 11.56B |
April 03, 2024 | 11.70B |
April 02, 2024 | 11.82B |
April 01, 2024 | 12.08B |
March 28, 2024 | 12.23B |
March 27, 2024 | 12.13B |
March 26, 2024 | 11.77B |
March 25, 2024 | 11.93B |
March 22, 2024 | 11.99B |
March 21, 2024 | 12.15B |
March 20, 2024 | 11.97B |
March 19, 2024 | 11.85B |
Date | Value |
---|---|
March 18, 2024 | 11.78B |
March 15, 2024 | 11.73B |
March 14, 2024 | 11.86B |
March 13, 2024 | 12.05B |
March 12, 2024 | 12.25B |
March 11, 2024 | 12.28B |
March 08, 2024 | 12.15B |
March 07, 2024 | 12.36B |
March 06, 2024 | 12.16B |
March 05, 2024 | 12.10B |
March 04, 2024 | 12.18B |
March 01, 2024 | 12.09B |
February 29, 2024 | 12.08B |
February 28, 2024 | 12.17B |
February 27, 2024 | 12.23B |
February 26, 2024 | 12.31B |
February 23, 2024 | 12.78B |
February 22, 2024 | 12.78B |
February 21, 2024 | 13.40B |
February 20, 2024 | 13.40B |
February 16, 2024 | 13.40B |
February 15, 2024 | 13.59B |
February 14, 2024 | 13.31B |
February 13, 2024 | 13.26B |
February 12, 2024 | 13.48B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.586B
Minimum
Oct 27 2023
22.80B
Maximum
Apr 28 2021
16.12B
Average
16.94B
Median
Oct 07 2019
Enterprise Value Benchmarks
Stryker Corp | 137.30B |
Masimo Corp | 7.989B |
NeuroMetrix Inc | -9.179M |
Insulet Corp | 12.41B |
Tandem Diabetes Care Inc | 2.112B |
Enterprise Value Related Metrics
Net Income (Quarterly) | 31.10M |
Revenue (Quarterly) | 773.91M |
Total Expenses (Quarterly) | 639.00M |
EPS Diluted (Quarterly) | 0.66 |
Gross Profit Margin (Quarterly) | 55.75% |
Profit Margin (Quarterly) | 4.02% |
Earnings Yield | 3.57% |
Operating Earnings Yield | 5.63% |
Normalized Earnings Yield | 4.024 |